Health
Researchers examine acriflavine’s antiviral potential against SARS-CoV-2 – News-Medical.Net
Acriflavine is traditionally employed as a topical antiseptic, though has more recently been implicated as an antiviral agent at low doses, potentially by stimulating…
Acriflavine is traditionally employed as a topical antiseptic, though has more recently been implicated as an antiviral agent at low doses, potentially by stimulating the production of interferon. In a new study recently uploaded to the bioRxiv* preprint server, the application of the drug to SARS-CoV-2 infection is investigated, demonstrating a broad activity towards a range of other betacoronaviruses.
Finding drug leads against SARS-CoV-2
Repurposing known drugs could be of vital importance in…
-
Noosa News24 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News23 hours agoAustralia Post reintroduces weekend deliveries for Christmas parcel rush
-
General19 hours agoFederal government funding extends cohealth GP services until July 2026
-
Noosa News17 hours agoSunshine Coast Airport receives green light for major upgrade opening doors to growth jobs and tourism across the region